Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Geraldine Goss"'
Autor:
Deborah Smith, Kristy P. Robledo, Sonia Yip, Michelle M. Cummins, Peey-Sei Kok, Yeh Chen Lee, Michael Friedlander, Sally Baron-Hay, Catherine Shannon, Jermaine Coward, Philip Beale, Geraldine Goss, Tarek Meniawy, Janine Lombard, Amanda B. Spurdle, John Andrews, Martin R. Stockler, Linda Mileshkin, Yoland Antill
Publikováno v:
Cancers, Vol 15, Iss 1, p 254 (2022)
Women with advanced endometrial carcinoma (EC) with mismatch repair (MMR) deficiency have improved outcomes when treated with immune checkpoint inhibitors; however, additional biomarkers are needed to identify women most likely to respond. Scores for
Externí odkaz:
https://doaj.org/article/d8180cf7bd7245d2b30058f4e920e1c5
Autor:
Linda Mileshkin, Elizabeth Barnes, Tarek Meniawy, Michael Friedlander, Geraldine Goss, Jermaine Coward, Yoland Antill, Michelle Cummins, Sally Baron-Hay, Martin R Stockler, Catherine Shannon, Philip Beale, Peey-Sei Kok, Deborah Smith, Sonia Yip, Amanda Spurdle, Yeh Chen Lee, Janine Lombard, John Andrews
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Background In this study, we assessed the activity of durvalumab, an antibody to programmed death ligand-1, in two cohorts of women with advanced endometrial cancers (AEC)—mismatch repair proficient (pMMR) and mismatch repair deficient (dMMR).Metho
Externí odkaz:
https://doaj.org/article/d96d05924ab04b6c8cd23204887b78f3
Publikováno v:
Cancer Research. 81:PS13-36
Background: Scalp cooling minimises chemotherapy-induced alopecia (CIA) which may reduce distress, improve quality of life and body image. This study assesses scalp-cooling efficacy in women receiving chemotherapy for early and advanced breast and ov
Autor:
Philip Beale, Yoland Antill, Sonia Yip, Amanda B. Spurdle, Kristy P. Robledo, Catherine Shannon, Elizabeth H Barnes, Deborah Smith, Tarek Meniawy, Peey-Sei Kok, Michelle M. Cummins, Michael Friedlander, Jermaine Coward, Sally Baron-Hay, Linda Mileshkin, Martin R. Stockler, John Andrews, Geraldine Goss, Janine M. Lombard, Yeh Chen Lee
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundIn this study, we assessed the activity of durvalumab, an antibody to programmed death ligand-1, in two cohorts of women with advanced endometrial cancers (AEC)—mismatch repair proficient (pMMR) and mismatch repair deficient (dMMR).Method
Autor:
Ina M. Jürgenliemk-Schulz, Ludy C.H.W. Lutgens, Marie Helene Baron, V. Do, Karen W Verhoeven-Adema, C. Post, Nelleke Ottevanger, Carien L. Creutzberg, Christine Haie-Meder, Jonathan A. Ledermann, Susan Brooks, Geraldine Goss, Linda Mileshkin, Anthony Fyles, Paul Bessette, Melanie E Powell, Roldano Fossati, Mary McCormack, Stephanie M. de Boer, Henry C Kitchener, Andrea Lissoni, Alexandra Leary, Vincent T.H.B.M. Smit, Romerai D'Amico, Amanda Feeney, Dionyssios Katsaros, Remi A. Nout, Hans W. Nijman, Hein Putter, Prafull Ghatage, Pearly Khaw
Publikováno v:
International Journal of Radiation Oncology-Biology-Physics, 109(4), 975-986. ELSEVIER SCIENCE INC
International Journal of Radiation Oncology, Biology, Physics, 109, 975-986
International Journal of Radiation Oncology Biology Physics, 109(4), 975-986. Elsevier Science
International Journal of Radiation Oncology, Biology, Physics, 109(4), 975-986. ELSEVIER SCIENCE INC
International Journal of Radiation Oncology, Biology, Physics, 109, 4, pp. 975-986
International journal of radiation oncology, biology, physics, 109(4), 975-986. Elsevier
International Journal of Radiation Oncology, Biology, Physics, 109, 975-986
International Journal of Radiation Oncology Biology Physics, 109(4), 975-986. Elsevier Science
International Journal of Radiation Oncology, Biology, Physics, 109(4), 975-986. ELSEVIER SCIENCE INC
International Journal of Radiation Oncology, Biology, Physics, 109, 4, pp. 975-986
International journal of radiation oncology, biology, physics, 109(4), 975-986. Elsevier
Contains fulltext : 232064.pdf (Publisher’s version ) (Open Access) PURPOSE: The survival results of the PORTEC-3 trial showed a significant improvement in both overall and failure-free survival with chemoradiation therapy versus pelvic radiation t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2798f409593ab83be7f21b7d7f100a58
http://www.redjournal.org/article/S0360301620344473/pdf
http://www.redjournal.org/article/S0360301620344473/pdf
Autor:
Hee Seung Kim, Michael Friedlander, Nivashini Kaliaperumal, John E. Connolly, Geraldine Goss, Jae Weon Kim, Jeffrey C. Goh, DIana G.Z. Lim, Bee Choo Tai, Natalie Ngoi, Wen Yee Chay, Kidong Kim, David S.P. Tan, Samuel Ow, Valerie Heong, Veonice Bijin Au, Chel Hun Choi
Publikováno v:
International Journal of Gynecological Cancer
BackgroundThe optimal treatment of recurrent ovarian clear cell carcinoma remains unknown. There is increasing rationale to support the role of immune checkpoint inhibitors targeting the programmed cell death protein 1 (PD-1)/programmed death-ligand
Autor:
Martin R. Stockler, Yeh Chen Lee, Linda Mileshkin, Peey-Sei Kok, Jermaine Coward, Philip Beale, Deborah Smith, Janine M. Lombard, Amanda B. Spurdle, Yoland Antill, Tarek Meniawy, Sonia Yip, Catherine Shannon, Michael Friedlander, Geraldine Goss, Kristy P. Robledo, Michelle M. Cummins, Sally Baron-Hay, John T. Andrews
Publikováno v:
Journal of Clinical Oncology. 39:5584-5584
5584 Background: Activity of durvalumab in patients with deficient mismatch repair (dMMR) advanced endometrial carcinoma (EC) was confirmed in the PHAEDRA trial (ANZGOG 1601). This study investigated the association between immune biomarkers and clin
Autor:
Michelle Parry, Linda Mileshkin, Amanda B. Spurdle, Deborah Smith, Yoland Antill, Catherine Shannon, Tarek Meniawy, Michael Friedlander, Philip Beale, Kristy P. Robledo, Marzena Kelly, John T. Andrews, Elizabeth H Barnes, Sally Baron-Hay, Geraldine Goss, Peey-Sei Kok, Martin R. Stockler, Jermaine Coward, Sonia Yip
Publikováno v:
Journal of Clinical Oncology. 37:5501-5501
5501 Background: Deficient DNA mismatch repair (dMMR) occurs in approximately 15% of AEC and is associated with a high tumour mutation burden. Expression of PD-1 and PD-L1 has been reported in up to 90% of ECs, including those with proficient DNA mis
Autor:
Geraldine Goss, George D. Demetri
Publikováno v:
Surgical Oncology. 9:53-59
Liposarcomas of the retroperitoneum are rare tumors, and best managed by an expert multidisciplinary team consisting of a surgical oncologist with appropriate medical oncology and radiation oncology collaboration. For large tumors, surgical excision
Autor:
Jeffrey G. Supko, Cecilia Guzman, Judith Manola, J. Jimeno, T. Lopez, Geraldine Goss, Rocio Garcia-Carbonero, George D. Demetri, Robert G. Maki, M. T. Quigley, David P. Ryan, M.A. Sancho, Aaron B. Waxman, Michael V. Seiden, Thomas A. Puchalski, David C. Harmon
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23(24)
Purpose To evaluate the response rate, toxicity profile, and pharmacokinetics of ecteinascidin-743 (ET-743) as first-line therapy in patients with unresectable advanced soft tissue sarcoma (STS). Patients and Methods Thirty-six patients with STS were